Read + Share
Amedeo Smart
Independent Medical Education
Humbert MV, Opurum PC, Brendish NJ, Poole S, et al. A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries. J Infect 2021 Oct 1. pii: S0163-4453(21)00492.PMID: 34606784
Email
LinkedIn
Facebook
Twitter
Privacy Policy